Mammalian O-mannosylation pathway: Glycan structures, enzymes, and protein Substrates

Biochemistry

Volumn 53, Issue 19, 2014, Pages 3066-3078

  Praissman, Jeremy L ^a   Wells, Lance ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYMES; MAMMALS; POLYSACCHARIDES;

BIOSYNTHETIC PATHWAY; CELL MATRIX INTERACTIONS; DISEASE PROCESS; GLYCAN STRUCTURES; POST-TRANSLATIONAL MODIFICATIONS; PROTEIN SUBSTRATE; RECENT PROGRESS;

PROTEINS;

ANIMALS; CARBOHYDRATE CONFORMATION; GLYCOSYLATION; HUMANS; MANNOSE; MANNOSYLTRANSFERASES; POLYSACCHARIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84901036287     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi500153y     Document Type: Article

References (116)

1. Varki, A., Eds. (2009) Essentials of Glycobiology, 2 nd ed., Cold Spring Harbor Laboratory Press, Plainview, NY.
2. Barresi, R. 2004, LARGE can functionally bypass α-dystroglycan glycosylation defects in distinct congenital muscular dystrophies Nat. Med. 10 (7) 696-703
3. Yoshida, A. 2001, Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1 Dev. Cell 1 (5) 717-724
4. Brockington, M. 2001, Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan Am. J. Hum. Genet. 69 (6) 1198-1209
5. Kuga, A. 2012, Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan J. Biol. Chem. 287 (12) 9560-9567
6. Lange, T. 2012, Human prostate cancer in a clinically relevant xenograft mouse model: Identification of β(1,6)-branched oligosaccharides as a marker of tumor progression Clin. Cancer Res. 18 (5) 1364-1373
7. Bao, X. 2009, Tumor suppressor function of laminin-binding α-dystroglycan requires a distinct β3-N-acetylglucosaminyltransferase Proc. Natl. Acad. Sci. U.S.A. 106 (29) 12109-12114
8. de Bernabe, D. B. 2009, Loss of α-dystroglycan laminin binding in epithelium-derived cancers is caused by silencing of LARGE J. Biol. Chem. 284 (17) 11279-11284
9. Esser, A. K. 2013, Loss of LARGE2 disrupts functional glycosylation of α-dystroglycan in prostate cancer J. Biol. Chem. 288 (4) 2132-2142
10. Barresi, R. and Campbell, K. P. (2006) Dystroglycan: From biosynthesis to pathogenesis of human disease J. Cell Sci. 119 (Part 2) 199-207
11. Sato, S. 2008, Pikachurin, a dystroglycan ligand, is essential for photoreceptor ribbon synapse formation Nat. Neurosci. 11 (8) 923-931
12. Beedle, A. M. 2012, Mouse fukutin deletion impairs dystroglycan processing and recapitulates muscular dystrophy J. Clin. Invest. 122 (9) 3330-3342
13. Yoshida-Moriguchi, T. 2010, O-mannosyl phosphorylation of α-dystroglycan is required for laminin binding Science 327 (5961) 88-92
14. Inamori, K. 2012, Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE Science 335 (6064) 93-96
15. Vester-Christensen, M. B. 2013, Mining the O-mannose glycoproteome reveals cadherins as major O-mannosylated glycoproteins Proc. Natl. Acad. Sci. U.S.A. 110, 21018-21023
16. Stalnaker, S. H. 2010, Site mapping and characterization of O-glycan structures on α-dystroglycan isolated from rabbit skeletal muscle J. Biol. Chem. 285 (32) 24882-24891
17. Harrison, R. 2012, Glycoproteomic characterization of recombinant mouse α-dystroglycan Glycobiology 22 (5) 662-675
18. Nilsson, J. 2010, Characterization of site-specific O-glycan structures within the mucin-like domain of α-dystroglycan from human skeletal muscle Glycobiology 20 (9) 1160-1169
19. Stalnaker, S. H. 2011, Glycomic analyses of mouse models of congenital muscular dystrophy J. Biol. Chem. 286 (24) 21180-21190
20. Gomez Toledo, A. 2012, O-Mannose and O-N-acetyl galactosamine glycosylation of mammalian α-dystroglycan is conserved in a region-specific manner Glycobiology 22 (11) 1413-1423
21. Jae, L. T. 2013, Deciphering the glycosylome of dystroglycanopathies using haploid screens for lassa virus entry Science 340 (6131) 479-483
22. Yoshida-Moriguchi, T. 2013, SGK196 is a glycosylation-specific O-mannose kinase required for dystroglycan function Science 341 (6148) 896-899
23. Ervasti, J. M. and Campbell, K. P. (1991) Membrane organization of the dystrophin-glycoprotein complex Cell 66 (6) 1121-1131
24. Ervasti, J. M. and Campbell, K. P. (1993) A role for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin J. Cell Biol. 122 (4) 809-823
25. Chai, W. 1999, High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis Eur. J. Biochem. 263 (3) 879-888
26. Beltran-Valero de Bernabe, D. 2002, Mutations in the O- mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome Am. J. Hum. Genet. 71 (5) 1033-1043
27. Satz, J. S. 2010, Distinct functions of glial and neuronal dystroglycan in the developing and adult mouse brain J. Neurosci. 30 (43) 14560-14572
28. Wright, K. M. 2012, Dystroglycan organizes axon guidance cue localization and axonal pathfinding Neuron 76 (5) 931-944
29. Kanekiyo, K. 2013, Loss of branched O-mannosyl glycans in astrocytes accelerates remyelination J. Neurosci. 33 (24) 10037-10047
30. Martin, P. T. (2007) Congenital muscular dystrophies involving the O-mannose pathway Curr. Mol. Med. 7 (4) 417-425
31. Lommel, M. 2013, Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion Proc. Natl. Acad. Sci. U.S.A. 110 (52) 21024-21029
32. Pacharra, S. 2013, The lecticans of mammalian brain perineural net are O-mannosylated J. Proteome Res. 12 (4) 1764-1771
33. Combs, A. C. and Ervasti, J. M. (2005) Enhanced laminin binding by α-dystroglycan after enzymatic deglycosylation Biochem. J. 390 (Part 1) 303-309
34. Thornton, D. J., Rousseau, K., and McGuckin, M. A. (2008) Structure and function of the polymeric mucins in airways mucus Annu. Rev. Physiol. 70, 459-486
35. Godfrey, C. 2007, Refining genotype phenotype correlations in muscular dystrophies with defective glycosylation of dystroglycan Brain 130 (Part 10) 2725-2735
36. Mercuri, E. 2009, Congenital muscular dystrophies with defective glycosylation of dystroglycan: A population study Neurology 72 (21) 1802-1809
37. Raducu, M. 2012, Promoter alteration causes transcriptional repression of the POMGNT1 gene in limb-girdle muscular dystrophy type 2O Eur. J. Hum. Genet. 20 (9) 945-952
38. Kizuka, Y. and Oka, S. (2012) Regulated expression and neural functions of human natural killer-1 (HNK-1) carbohydrate Cell. Mol. Life Sci. 69 (24) 4135-4147
39. Lee, I. 2006, N-acetylglucosaminyltranferase VB expression enhances β1 integrin-dependent PC12 neurite outgrowth on laminin and collagen J. Neurochem. 97 (4) 947-956
40. Abbott, K. L. 2006, Integrin-dependent neuroblastoma cell adhesion and migration on laminin is regulated by expression levels of two enzymes in the O-mannosyl-linked glycosylation pathway, PomGnT1 and GnT-Vb Exp. Cell Res. 312 (15) 2837-2850
41. Abbott, K. L., Matthews, R. T., and Pierce, M. (2008) Receptor tyrosine phosphatase β (RPTPβ) activity and signaling are attenuated by glycosylation and subsequent cell surface galectin-1 binding J. Biol. Chem. 283 (48) 33026-33035
42. Lee, J. K. 2012, Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V J. Biol. Chem. 287 (34) 28526-28536
43. Nakagawa, N., Takematsu, H., and Oka, S. (2013) HNK-1 sulfotransferase-dependent sulfation regulating laminin-binding glycans occurs in the post-phosphoryl moiety on α-dystroglycan Glycobiology 23 (9) 1066-1074
44. Inamori, K. 2012, Dystroglycan function requires xylosyl- and glucuronyltransferase activities of LARGE Science 335 (6064) 93-96
45. Tsuboi, S. 2012, Two opposing roles of O-glycans in tumor metastasis Trends Mol. Med. 18 (4) 224-232
46. Nakagawa, N. 2012, Human natural killer-1 sulfotransferase (HNK-1ST)-induced sulfate transfer regulates laminin-binding glycans on α-dystroglycan J. Biol. Chem. 287 (36) 30823-30832
47. Kunz, S. 2005, Posttranslational modification of α-dystroglycan, the cellular receptor for arenaviruses, by the glycosyltransferase LARGE is critical for virus binding J. Virol. 79 (22) 14282-14296
48. Goddeeris, M. M. 2013, LARGE glycans on dystroglycan function as a tunable matrix scaffold to prevent dystrophy Nature 503 (7474) 136-140
49. Mo, K. F. 2011, Synthetic, structural, and biosynthetic studies of an unusual phospho-glycopeptide derived from α-dystroglycan J. Am. Chem. Soc. 133 (36) 14418-14430
50. Manya, H. 2004, Demonstration of mammalian protein O-mannosyltransferase activity: Coexpression of POMT1 and POMT2 required for enzymatic activity Proc. Natl. Acad. Sci. U.S.A. 101 (2) 500-505
51. Akasaka-Manya, K., Manya, H., and Endo, T. (2004) Mutations of the POMT1 gene found in patients with Walker-Warburg syndrome lead to a defect of protein O-mannosylation Biochem. Biophys. Res. Commun. 325 (1) 75-79
52. van Reeuwijk, J. 2005, POMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome J. Med. Genet. 42 (12) 907-912
53. Mercuri, E. 2006, POMT2 mutation in a patient with MEB-like phenotype Neuromuscular Disord. 16 (7) 446-448
54. van Reeuwijk, J. 2006, The expanding phenotype of POMT1 mutations: From Walker-Warburg syndrome to congenital muscular dystrophy, microcephaly, and mental retardation Hum. Mutat. 27 (5) 453-459
55. Lommel, M. 2010, Correlation of enzyme activity and clinical phenotype in POMT1-associated dystroglycanopathies Neurology 74 (2) 157-164
56. Willer, T. 2004, Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality Proc. Natl. Acad. Sci. U.S.A. 101 (39) 14126-14131
57. Hu, H. 2011, Conditional knockout of protein O-mannosyltransferase 2 reveals tissue-specific roles of O-mannosyl glycosylation in brain development J. Comp. Neurol. 519 (7) 1320-1337
58. Tran, D. T. 2012, Glycosylation of α-dystroglycan: O-Mannosylation influences the subsequent addition of GalNAc by UDP-GalNAc polypeptide N-acetylgalactosaminyltransferases J. Biol. Chem. 287 (25) 20967-20974
59. Liu, M. 2008, Conformational consequences of protein glycosylation: Preparation of O-mannosyl serine and threonine building blocks, and their incorporation into glycopeptide sequences derived from α-dystroglycan Biopolymers 90 (3) 358-368
60. Breloy, I. 2008, Initiation of mammalian O-mannosylation in vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the α-dystroglycan mucin domain J. Biol. Chem. 283 (27) 18832-18840
61. Manya, H. 2010, Role of N-glycans in maintaining the activity of protein O-mannosyltransferases POMT1 and POMT2 J. Biochem. 147 (3) 337-344
62. Willer, T. 2012, ISPD loss-of-function mutations disrupt dystroglycan O-mannosylation and cause Walker-Warburg syndrome Nat. Genet. 44 (5) 575-580
63. Manzini, M. C. 2012, Exome sequencing and functional validation in zebrafish identify GTDC2 mutations as a cause of Walker-Warburg syndrome Am. J. Hum. Genet. 91 (3) 541-547
64. Stevens, E. 2013, Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan Am. J. Hum. Genet. 92 (3) 354-365
65. Hiruma, T. 2004, A novel human β1,3-N- acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAcβ1-3GlcNAc J. Biol. Chem. 279 (14) 14087-14095
66. Vogel, P. 2012, Congenital hydrocephalus in genetically engineered mice Vet. Pathol. 49 (1) 166-181
67. Ogawa, M. 2013, GTDC2 modifies O-mannosylated α-dystroglycan in the endoplasmic reticulum to generate N-acetyl glucosamine epitopes reactive with CTD110.6 antibody Biochem. Biophys. Res. Commun. 440 (1) 88-93
68. Hara, Y. 2011, Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection Proc. Natl. Acad. Sci. U.S.A. 108 (42) 17426-17431
69. Gill, D. J. 2010, Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes J. Cell Biol. 189 (5) 843-858
70. Soderberg, T. (2010) Organic Chemistry with a Biological Emphasis, Vol. II.
71. Ashikov, A. 2013, LARGE2 generates the same xylose- and glucuronic acid-containing glycan structures as LARGE Glycobiology 23 (3) 303-309
72. Inamori, K. 2013, Xylosyl- and glucuronyltransferase functions of LARGE in α-dystroglycan modification are conserved in LARGE2 Glycobiology 23 (3) 295-302
73. Zhang, P. and Hu, H. (2012) Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase Glycobiology 22 (2) 235-247
74. Grewal, P. K. 2005, Characterization of the LARGE family of putative glycosyltransferases associated with dystroglycanopathies Glycobiology 15 (10) 912-923
75. Kanagawa, M. 2009, Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy Hum. Mol. Genet. 18 (4) 621-631
76. Rojek, J. M. 2007, Old World arenavirus infection interferes with the expression of functional α-dystroglycan in the host cell Mol. Biol. Cell 18 (11) 4493-4507
77. Patnaik, S. K. and Stanley, P. (2005) Mouse large can modify complex N- and mucin O-glycans on α-dystroglycan to induce laminin binding J. Biol. Chem. 280 (21) 20851-20859
78. Hu, Y. 2011, Large induces functional glycans in an O-mannosylation dependent manner and targets GlcNAc terminals on α-dystroglycan PLoS One 6 (2) e16866
79. Aguilan, J. T. 2009, Mutational and functional analysis of Large in a novel CHO glycosylation mutant Glycobiology 19 (9) 971-986
80. Nakagawa, N. 2011, Sulfation of glucuronic acid in the linkage tetrasaccharide by HNK-1 sulfotransferase is an inhibitory signal for the expression of a chondroitin sulfate chain on thrombomodulin Biochem. Biophys. Res. Commun. 415 (1) 109-113
81. Gerardy-Schahn, R., Oelmann, S., and Bakker, H. (2001) Nucleotide sugar transporters: Biological and functional aspects Biochimie 83 (8) 775-782
82. Zhao, W. 2006, The CMP-sialic acid transporter is localized in the medial-trans Golgi and possesses two specific endoplasmic reticulum export motifs in its carboxyl-terminal cytoplasmic tail J. Biol. Chem. 281 (41) 31106-31118
83. Kanagawa, M. 2004, Molecular recognition by LARGE is essential for expression of functional dystroglycan Cell 117 (7) 953-964
84. Hara, Y. 2011, A dystroglycan mutation associated with limb-girdle muscular dystrophy N. Engl. J. Med. 364 (10) 939-946
85. Roscioli, T. 2012, Mutations in ISPD cause Walker-Warburg syndrome and defective glycosylation of α-dystroglycan Nat. Genet. 44 (5) 581-585
86. Kuchta, K. 2009, Comprehensive classification of nucleotidyltransferase fold proteins: Identification of novel families and their representatives in human Nucleic Acids Res. 37 (22) 7701-7714
87. Harnett, W., Rzepecka, J., and Houston, K. M. (2010) How do nematodes transfer phosphorylcholine to carbohydrates? Trends Parasitol. 26 (3) 114-118
88. Van Reeuwijk, J. 2010, A homozygous FKRP start codon mutation is associated with Walker-Warburg syndrome, the severe end of the clinical spectrum Clin. Genet. 78 (3) 275-281
89. Xiong, H. 2006, Molecular interaction between fukutin and POMGnT1 in the glycosylation pathway of α-dystroglycan Biochem. Biophys. Res. Commun. 350 (4) 935-941
90. Yamamoto, T. 2006, Intracellular binding of fukutin and α-dystroglycan: Relation to glycosylation of α-dystroglycan Neurosci. Res. 56 (4) 391-399
91. Esapa, C. T. 2002, Functional requirements for fukutin-related protein in the Golgi apparatus Hum. Mol. Genet. 11 (26) 3319-3331
92. Tachikawa, M. 2012, Mislocalization of fukutin protein by disease-causing missense mutations can be rescued with treatments directed at folding amelioration J. Biol. Chem. 287 (11) 8398-8406
93. Lin, Y. Y. 2011, Zebrafish Fukutin family proteins link the unfolded protein response with dystroglycanopathies Hum. Mol. Genet. 20 (9) 1763-1775
94. Jimenez-Mallebrera, C. 2009, A comparative study of α-dystroglycan glycosylation in dystroglycanopathies suggests that the hypoglycosylation of α-dystroglycan does not consistently correlate with clinical severity Brain Pathol. 19 (4) 596-611
95. Sztal, T. E. 2012, Epistatic dissection of laminin-receptor interactions in dystrophic zebrafish muscle Hum. Mol. Genet. 21 (21) 4718-4731
96. Blaeser, A. 2013, Mouse models of fukutin-related protein mutations show a wide range of disease phenotypes Hum. Genet. 132 (8) 923-934
97. Kawahara, G. 2010, Zebrafish models for human FKRP muscular dystrophies Hum. Mol. Genet. 19 (4) 623-633
98. Lynch, T. A. 2012, Detection of the dystroglycanopathy protein, fukutin, using a new panel of site-specific monoclonal antibodies Biochem. Biophys. Res. Commun. 424 (2) 354-357
99. Vuillaumier-Barrot, S. 2012, Identification of mutations in TMEM5 and ISPD as a cause of severe cobblestone lissencephaly Am. J. Hum. Genet. 91 (6) 1135-1143
100. Clement, E. M. 2008, Mild POMGnT1 mutations underlie a novel limb-girdle muscular dystrophy variant Arch. Neurol. 65 (1) 137-141
101. Lan, J. 2013, O-linked mannose β-1,2-N-acetylglucosaminyltransferase 1 correlated with the malignancy in glioma Journal of Craniofacial Surgery 24 (4) 1441-1446
102. Inamori, K. 2004, N-Acetylglucosaminyltransferase IX acts on the GlcNAc β1,2-Manα1-Ser/Thr moiety, forming a 2,6-branched structure in brain O-mannosyl glycan J. Biol. Chem. 279 (4) 2337-2340
103. Cirak, S. 2013, ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies Brain 136 (Part 1) 269-281
104. Tasca, G. 2013, Limb-girdle muscular dystrophy with α-dystroglycan deficiency and mutations in the ISPD gene Neurology 80 (10) 963-965
105. Nishihara, S. 2003, α1,3-Fucosyltransferase IX (Fut9) determines Lewis X expression in brain Glycobiology 13 (6) 445-455
106. Kudo, T. 2007, Mice lacking α1,3-fucosyltransferase IX demonstrate disappearance of Lewis x structure in brain and increased anxiety-like behaviors Glycobiology 17 (1) 1-9
107. Kakuda, S. 2005, Different acceptor specificities of two glucuronyltransferases involved in the biosynthesis of HNK-1 carbohydrate Glycobiology 15 (2) 203-210
108. Morise, J. 2014, Structural and biochemical characterization of O-mannose-linked human natural killer-1 glycan expressed on phosphacan in developing mouse brains Glycobiology 24 (3) 314-324
109. Finne, J. 1979, Novel mannitol-containing oligosaccharides obtained by mild alkaline borohydride treatment of a chondroitin sulfate proteoglycan from brain J. Biol. Chem. 254 (20) 10295-10300
110. Chiba, A. 1997, Structures of sialylated O-linked oligosaccharides of bovine peripheral nerve α-dystroglycan. The role of a novel O-mannosyl-type oligosaccharide in the binding of α-dystroglycan with laminin J. Biol. Chem. 272 (4) 2156-2162
111. Smalheiser, N. R. 1998, Structural analysis of sequences O-linked to mannose reveals a novel Lewis X structure in cranin (dystroglycan) purified from sheep brain J. Biol. Chem. 273 (37) 23698-23703
112. Sasaki, T. 1998, Detection of O-mannosyl glycans in rabbit skeletal muscle α-dystroglycan Biochim. Biophys. Acta 1425 (3) 599-606
113. Bleckmann, C. 2009, O-glycosylation pattern of CD24 from mouse brain Biol. Chem. 390 (7) 627-645
114. Martinez, T. 2007, Characterization of a novel modification on IgG2 light chain. Evidence for the presence of O-linked mannosylation J. Chromatogr., A 1156 (1-2) 183-187
115. Pacharra, S., Hanisch, F. G., and Breloy, I. (2012) Neurofascin 186 is O-mannosylated within and outside of the mucin domain J. Proteome Res. 11 (8) 3955-3964
116. Yuen, C. T. 1997, Brain contains HNK-1 immunoreactive O-glycans of the sulfoglucuronyl lactosamine series that terminate in 2-linked or 2,6-linked hexose (mannose) J. Biol. Chem. 272 (14) 8924-8931